MATWIN’s platform objectives
MATWIN (Maturation & Accelerating Translation With Industry) is the only French open-innovation platform specifically dedicated to oncology. MATWIN, a wholly owned subsidiary of Unicancer group (gathering all the French Comprehensive Cancer Centres) offers several actions (expertise, accelerating program, events, etc.) aiming at accelerating the development of innovative projects dedicated to the fight against cancer.
Research
Strenghten innovations’ transfer potential in partnership with the national ecosystem (canceropôles, TTOs, clusters …
Industry
Mutualize a sourcing platform of « shortlisted » early innovative projects
Patients
Contribute to accelerate treatments/ diagnostics outlooks
How to work with MATWIN ?
MATWIN in figures
applicants
projects interviewed by the board
start-up created
projects transferred
participants for meet2win
MEET2WIN : our annual partnering convention dedicated to open innovation in oncology
News
In’CaRe: Call for projects in Oncology and Hematology
Cancers are still a major public health issue. Promoting innovation in oncology in France therefore remains a priority. AstraZeneca demonstrates [...]
The Amgen France Fund for Science and Humans launches its 4th call for projects
Following the success of previous calls for projects, the Amgen France Fund for Science and Humans is launching a fourth [...]
Newsletter MATWIN June 2023
Download here the latest MATWIN newsletter :